Heartburn Cancer Lawsuit: NY Legal Options Explained

A heartburn cancer lawsuit is a product liability claim alleging that a heartburn medication — most notably Zantac (ranitidine) — caused cancer due to contamination with the carcinogen NDMA. Plaintiffs nationwide, including many in New York, have sued manufacturers for failing to warn consumers about this risk. These cases typically allege design defect, failure to warn, and negligence.

Ranitidine (Zantac) has been associated with several cancers, including bladder cancer, stomach cancer, esophageal cancer, colorectal cancer, and kidney cancer. The FDA recalled all ranitidine products in 2020 after finding that NDMA levels increased over time and with storage temperature. If you were diagnosed with one of these cancers after prolonged use, you should speak with a NY attorney.

In New York, the statute of limitations for personal injury claims is generally three years under CPLR §214. Under CPLR §214-c, New York's discovery rule for latent injuries, the clock may instead run from the date you discovered, or reasonably should have discovered, that your cancer was linked to ranitidine. However, product liability and cancer diagnosis cases can involve complex accrual rules, and some claims may be subject to different timelines. Because deadlines are strict and fact-specific, you should consult a NY personal injury attorney as soon as possible.

To succeed in a product liability claim in New York, you generally must show that you took the medication (such as Zantac) for a significant period, that the drug was defective or lacked adequate warnings, and that its use caused or substantially contributed to your cancer diagnosis. Medical records, prescription history, and expert testimony linking NDMA exposure to your specific cancer are critical. Document everything and preserve all records.